Article Versions Notes

Jiang H, Jin P, Guo X, Zhu J, Wang X, Wan P, Wan J, Liu J, Li J, Zhu F. The 6-Month Antibody Durability of Heterologous Convidecia Plus CoronaVac and Homologous CoronaVac Immunizations in People Aged 18–59 Years and over 60 Years Based on Two Randomized Controlled Trials in China. Vaccines. 2023; 11(12):1815. https://doi.org/10.3390/vaccines11121815

Jiang, Hudachuan, Pengfei Jin, Xiling Guo, Jiahong Zhu, Xue Wang, Peng Wan, Jingxuan Wan, Jingxian Liu, Jingxin Li, and Fengcai Zhu. 2023. "The 6-Month Antibody Durability of Heterologous Convidecia Plus CoronaVac and Homologous CoronaVac Immunizations in People Aged 18–59 Years and over 60 Years Based on Two Randomized Controlled Trials in China" Vaccines 11, no. 12: 1815. https://doi.org/10.3390/vaccines11121815

Jiang, H., Jin, P., Guo, X., Zhu, J., Wang, X., Wan, P., Wan, J., Liu, J., Li, J., & Zhu, F. (2023). The 6-Month Antibody Durability of Heterologous Convidecia Plus CoronaVac and Homologous CoronaVac Immunizations in People Aged 18–59 Years and over 60 Years Based on Two Randomized Controlled Trials in China. Vaccines, 11(12), 1815. https://doi.org/10.3390/vaccines11121815